Haiming Cao;Gokhan S. Hotamisligil;Dariush Mozaffarian
发明人:
Dariush Mozaffarian,Haiming Cao,Gokhan S. Hotamisligil
申请号：
US13809181
公开号：
US08889739B2
申请日:
2011.07.11
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low concentrations of trans-C16:1n7-palmitoleate the serum indicates a risk of metabolic disease. Additionally, administering trans C16:1n7-palmitoleate to a subject (via pharmaceutical, nutraceutical, or other means), positively impacts glucose metabolism.
